Seborrheic dermatitis Skin and Connective Tissue Diseases Dermatitis
Conditions
Interventions
Group 1: pimecrolimus 1% cream applied twice daily for 2 weeks
Group 2: hydrocortisone acetate 1% cream applied twice daily for 2 weeks
Sponsors
Tehran University of Medical Sciences (Iran) - Center for Research and Training in Skin Diseases and Leprosy
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients with facial seborrheic dermatitis older than 8 years.
Exclusion criteria
Exclusion criteria: 1. Presence of active malignancy on the facial lesion 2. Presence of any kind of active viral skin disease on the facial lesion 3. Use of oral steroids in the past two weeks 4. Use of psoralen plus ultraviolet A (PUVA), ultraviolet B (UVB), ultraviolet A (UVA), azathioprine or cyclosporin in past month 5. Application of any topical treatment in past week 6. Use of any systemic antibiotics or antifungals in past 2 weeks 7. Attending in any other research study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Clinical response (erythema, pruritis, scaling) at 2, 4 and 6 weeks after treatment 2. Patient's general perception about treatment result 3. Adverse events in each treatment group | — |
Secondary
| Measure | Time frame |
|---|---|
| Not provided at time of registration | — |
Countries
Iran
Outcome results
None listed